References
- H. Thomas and H.M. Coley, Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer Control, 10, 159-65 (2003)
- B. Desoize and J.C. Jardillier, Multicellular resistance: a paradism for clinical resistance? Crit. Rev. Oncol/Hematology, 36, 193-207 (2000) https://doi.org/10.1016/S1040-8428(00)00086-X
- H. Jaeschke, Cellular adhesion molecules : regulation and functional signification in the pathogenesis of liver diseases. Am. J. Physiol., 36, G602-11 (1997)
- P.A.J. Henricks and F.P. Nijkamp, Pharmacological modulation of cell adhesion molecules. Eur. J. Pharmacol., 344, 1-13 (1998) https://doi.org/10.1016/S0014-2999(98)00036-3
- R.M. Sutherland, W.R. Inch, J.A. McCredie and J. Kruuv, A multicomponent radiation survival curve using an in vitro tumor model. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 18, 491-5 (1970) https://doi.org/10.1080/09553007014551401
- W.R. Inch, J.A. McCredie and R.M. Sutherland, Growth of nodular carcinomas in rodents compared with multi-cell spheroids in tissue culture. Growth, 34, 271-82 (1970)
- R.M. Sutherland, J.A. McCredie and W.R. Inch, Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J. Natl. Cancer Inst., 46, 113-20 (1971)
- W. Mueller-Klieser, Multicellular spheroids. A review on cellular aggregates in cancer research. J. Cancer Res. Clin. Oncol., 113, 101-22 (1987) https://doi.org/10.1007/BF00391431
- R.M. Sutherland, Cell and environment interactions in tumor microregions: the multicell spheroid model. Science, 8, 177-84 (1988) https://doi.org/10.1126/science.ns-8.186.177
- R. Knuechel and R.M. Sutherland, Recent developments in research with human tumor spheroids. Cancer J., 3, 234-43 (1990)
- R. Bjerkvig, M. Lund-Johansen and K. Edvardsen, Tumor cell invasion and angiogenesis in the central nervous system. Curr. Opin. Oncol., 3, 223-9 (1997)
- A. Frankel, S. Man, P. Elliott, J. Adams and R.S. Kerbel, Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin. Cancer Res., 6, 3719-28 (2000)
- G. Rainaldi, A. Calcabrini, G. Arancia and M.T. Santini, Differential expression of adhesion molecules (CD44, ICAM-1 and LFA-3) in cancer cells grown in monolayer or as multicellular spheroids. Anticancer Res., 19, 1769-78 (1999)
- R. Demicheli, R. Foroni, A. Ingrosso, G. Pratesi, C. Soranzo and M. Tortoreto, An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data. Cancer Res., 1, 6543-6 (1989)
- R. Demicheli, G. Pratesi and R. Foroni, The exponential-Gompertzian tumor growth model: data from six tumor cell lines in vitro and in vivo. Estimate of the transition point from exponential to Gompertzian growth and potential clinical implications. Tumori., 30, 189-95 (1991)
-
St Croix B., V.A. Florenes, J.W. Rak, M. Flanagan, N. Bhattacharya, J.M. Slingerland and R.S. Kerbel, Impact of the cyclin-dependent kinase inhibitor
$p27^{kip1}$ on resistance of tumor cells to anticancer agents. Nat. Med., 2, 1204-10 (1996) https://doi.org/10.1038/nm1196-1204 - R.S. Kerbel, St Croix B., V.A. Florenes and J. Rak, Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors. Hum. Cell, 9, 257-64 (1996)
- E. Sham and R.E. Durand, Cell kinetics and repopulation mechanisms during multifraction irradiation of spheroids. Radiother. Oncol., 46, 201-7 (1998) https://doi.org/10.1016/S0167-8140(97)00193-X
- R.M. Mader, M. Muller, G.G. Steger, Resistant to 5-Fluorouracil. Gen. Pharmacal., 31, 661-6 (1998) https://doi.org/10.1016/S0306-3623(98)00191-8
- R.C. Bates et aI., Apoptosis induced by inhibition of intracellular contact. J. Cell Biol., 125, 403-15 (1994) https://doi.org/10.1083/jcb.125.2.403
- R.M. Phillips, A. de la Cruz and R.D. Traver et aI., Increased activity and expression of NAD(P)H: quinone acceptor oxidoreductase in confluent cell cultures and within multicellular spheroids. Cancer Res., 54, 3766-71 (1994)
- E.M. Zeman, J.M. Brown, M.J. Lemmon, V.K. Hirst and W.W. Lee, SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int. J. Radiat. Oncol. Biol. Phys., 12, 1239-42 (1986) https://doi.org/10.1016/0360-3016(86)90267-1
- J.M. Brown, SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. Br. J. Cancer, 67, 1163-70 (1993) https://doi.org/10.1038/bjc.1993.220
- M. Hockel, K. Schlenger, M. Mitze, U. Schaffer and P. Vaupel, Hypoxia and Radiation Response in Human Tumors. Semin. Radiat. Oneal., 6, 3-9 (1996) https://doi.org/10.1016/S1053-4296(96)80031-2
- I.R. Freshney, Culture of animal cells. New York Alan R. Liss, Inc., 297-307 (1987)
- R.E. Durand and P.L. Olive, Evaluation of bioreductive drugs in multicell spheroids. Int. Radiat. Oneal. Biol. Phys., 22, 689-92 (1992) https://doi.org/10.1016/0360-3016(92)90504-B